References
Tangerine
4912
Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
28601
Murakami, A., Nakamura, Y., Ohto, Y., Yano, M., Koshiba, T., Koshimizu, K., Tokuda, H., Nishino, H., and Ohigashi, H. Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. Biofactors 2000;12(1-4):187-192. View abstract.
28603
Sugiyama, S., Umehara, K., Kuroyanagi, M., Ueno, A., and Taki, T. Studies on the differentiation inducers of myeloid leukemic cells from Citrus species. Chem Pharm Bull (Tokyo) 1993;41(4):714-719. View abstract.
28604
Kim, M. J., Park, H. J., Hong, M. S., Park, H. J., Kim, M. S., Leem, K. H., Kim, J. B., Kim, Y. J., and Kim, H. K. Citrus Reticulata blanco induces apoptosis in human gastric cancer cells SNU-668. Nutr Cancer 2005;51(1):78-82. View abstract.
28605
Kang, S. A., Park, H. J., Kim, M. J., Lee, S. Y., Han, S. W., and Leem, K. H. Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol 2005;97(2):231-235. View abstract.
28607
Tian, Q., Miller, E. G., Ahmad, H., Tang, L., and Patil, B. S. Differential inhibition of human cancer cell proliferation by citrus limonoids. Nutr Cancer 2001;40(2):180-184. View abstract.
28608
Yuan, J. M., Wang, X. L., Xiang, Y. B., Gao, Y. T., Ross, R. K., and Yu, M. C. Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 2000;85(3):358-363. View abstract.
28609
Backman, J. T., Maenpaa, J., Belle, D. J., Wrighton, S. A., Kivisto, K. T., and Neuvonen, P. J. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation. Clin Pharmacol Ther 2000;67(4):382-390. View abstract.
28610
Vilaplana, J. and Romaguera, C. Contact dermatitis from the essential oil of tangerine in fragrance. Contact Dermatitis 2002;46(2):108. View abstract.
28611
Aslan, A., Unal, I., Karaguzel, G., and Melikoglu, M. A case of intestinal obstruction due to phytobezoar--an alternative surgical approach. Swiss Surg 2003;9(1):35-37. View abstract.
28612
Skala, J. and Komarek, J. [Obstruction of the small intestine due to orange and tangerine]. Rozhl Chir 1976;55(4):252-253. View abstract.
28613
Wingerath, T., Stahl, W., and Sies, H. beta-Cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in beta-cryptoxanthin esters. Arch Biochem Biophys 1995;324(2):385-390. View abstract.
28614
Ho SC, Kuo CT. Hesperidin, nobiletin, and tangeretin are collectively responsible for the anti-neuroinflammatory capacity of tangerine peel (Citri reticulatae pericarpium). Food Chem Toxicol 2014;71:176-82. View abstract.
28615
Liao J, Xu T, Liu YH, Wang SZ. A new limonoid from the seeds of Citrus reticulata Blanco. Nat Prod Res 2012;26(8):756-61. View abstract.
43416
Li, Y., Xu, C., Zhang, Q., Liu, J. Y., and Tan, R. X. In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicines used to treat ulcer diseases. J Ethnopharmacol 4-26-2005;98(3):329-333. View abstract.
53350
Rincon, A. M., Vasquez, A. M., and Padilla, F. C. [Chemical composition and bioactive compounds of flour of orange (Citrus sinensis), tangerine (Citrus reticulata) and grapefruit (Citrus paradisi) peels cultivated in Venezuela]. Arch Latinoam Nutr 2005;55(3):305-310. View abstract.
54757
Vinson, J. A., Liang, X., Proch, J., Hontz, B. A., Dancel, J., and Sandone, N. Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease. Adv Exp Med Biol 2002;505:113-122. View abstract.